DNA Script is a leading provider of Enzymatic DNA Synthesis (EDS) products, which incorporate unique patented features.
This page is intended to serve as notice under 35 U.S.C. § 287(a).
SYNTAX STX-200 SYSTEM
SYNTAX STX-100 SYSTEM
PRODUCT NUMBERS: 100296, 100094, 100316, and 101773
This product and its use are the subject of (i) one or more issued and/or pending US and foreign patents/patent applications owned by DNA Script SAS, including US10,837,040, (collectively “DNA Script Instrument Patent Rights”), and (ii) U.S. Patent No. 8,034,923 owned by Dynamic Combinatorial Chemistry LLC. and licensed to DNA Script SAS. Purchase of the product from DNA Script SAS, or from a DNA Script-authorized distributor, conveys to the purchaser a non-exclusive, limited, non-transferable right under (i) the DNA Script Instrument Patent Rights, and (ii) process claims 1-4 of US Patent No. 8,034,923, to use the SYNTAX nucleic acid synthesis instrument to synthesize DNA polynucleotides by untemplated DNA synthesis using the below-listed DNA Script SYNTAX Reagent Kits purchased from DNA Script only for internal, non-commercial, research purposes. Any use of this product other than for internal, non-commercial research requires a commercial license; please contact DNA Script SAS for further information.
Kits
PRODUCT NUMBERS: 100134, 100294, 100274, 100852, 100853, 100854, 100855, 100856, 101867, 101868, 101869, 101870, and 101871
These products and their use are the subject of (i) one or more issued and/or pending US and foreign patents/patent applications, owned by DNA Script SAS, including US11,359,221 and US11,905,541 for kits #100134, #100294, #100274, #100854, #100855, #100856, #101868, #101869, #101870, #101871, (collectively “DNA Script DNA Synthesis Patent Rights”), and (ii) U.S. Patent Nos. 7,544,794 and 8,034,923 owned by Dynamic Combinatorial Chemistry LLC and licensed to DNA Script SAS. Purchase of these products from DNA Script SAS, or from a DNA Script-authorized distributor, conveys to the purchaser a non-exclusive, limited, non-transferable right under (i) the DNA Script DNA Synthesis Patent Rights, and (ii) US Patent No. 7,544,794 (claims 1 and 6 only) and US Patent No. 8,034,923 (claims 1-4 only), to use the purchased product to synthesize DNA polynucleotides by untemplated DNA synthesis using a DNA Script SYNTAX nucleic acid synthesis instrument, and to cleave the synthesized DNA polynucleotides from the solid support using components provided in those Kits only for internal, non-commercial research purposes, and does not include any right to make or have made the purchased product. Any use of this product other than for internal, non-commercial research requires a commercial license; please contact DNA Script SAS for further information.